U.S. inspectors listed serious problems in 2022 that could have resulted in strict measures like a pause in production. But the plant continued operating, and some conditions persisted.
Related Posts
South African AIDS Activist Pushes for H.I.V. Treatment Access After U.S.-Aid Cuts
Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as…
Kennedy’s Plan for the Drug Crisis: A Network of ‘Healing Farms’
The positions of Robert F. Kennedy Jr. on vaccines and drug companies are well known. His approach to addiction has…
Jillian Sackler, Philanthropist Who Defended Husband’s Legacy, Dies at 84
Though the Sackler name was tarnished over Purdue Pharma’s role in the opioid crisis, Arthur Sackler’s should not be, she…